Xiaoli Huang (Former)
1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
(
- Contribution to journal › Article
- 2021
-
Mark
Breast cancer cell line toxicity of a flavonoid isolated from Baccharis densiflora
(
- Contribution to journal › Article
-
Mark
Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration
(
- Contribution to journal › Article
- 2019
-
Mark
Extracellular and intracellular small-molecule galectin-3 inhibitors
(
- Contribution to journal › Article
- 2018
-
Mark
The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin
(
- Contribution to journal › Article
-
Mark
Aromatic heterocycle galectin-1 interactions for selective single-digit nM affinity ligands
(
- Contribution to journal › Article
-
Mark
Quinoline-galactose hybrids bind selectively with high affinity to a galectin-8 N-terminal domain
(
- Contribution to journal › Article
- 2017
-
Mark
Structure–Activity Relationships in Salinomycin : Cytotoxicity and Phenotype Selectivity of Semi-synthetic Derivatives
(
- Contribution to journal › Article
-
Mark
Anti-cancer stem cell activity of a sesquiterpene lactone isolated from Ambrosia arborescens and of a synthetic derivative
(
- Contribution to journal › Article
- 2016
-
Mark
Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs.
(
- Contribution to journal › Article